Stay updated on OPTIMISE Clinical Trial: Secukinumab in Psoriasis

Sign up to get notified when there's something new on the OPTIMISE Clinical Trial: Secukinumab in Psoriasis page.
Latest website image capture
Clouds background image

Latest updates to the OPTIMISE Clinical Trial: Secukinumab in Psoriasis page

  1. Check
    yesterday
    Change Detected
    Summary
    A site-wide NIH notice announces transition updates and says some content may use “Super Intelligence” instead of “Artificial Intelligence.”
    Difference
    1%
    Check dated 2026-10-24T15:36:15.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changes from v3.7.1 to v3.7.2; the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-17T15:21:05.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The site revision label changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T15:23:44.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Difference
    17%
    Check dated 2026-09-19T18:23:50.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.5 to v3.6.6, indicating a new version of the page. The previous revision tag was removed.
    Difference
    0.0%
    Check dated 2026-08-29T20:20:10.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    - The page version changed from v3.6.4 to v3.6.5, indicating a minor platform update. No study content or data changes are apparent.
    Difference
    0.0%
    Check dated 2026-08-08T18:28:30.000Z thumbnail image

Stay in the know with updates to OPTIMISE Clinical Trial: Secukinumab in Psoriasis

Enter your email address, and we'll notify you when there's something new on the OPTIMISE Clinical Trial: Secukinumab in Psoriasis page.